Sponsor

Peking University International Hospital

Clinical research sponsor

Published trials6

Recruiting shown2

Roles1

SourceClinicalTrials.gov

Clinical trials

6 shown

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsNCT07586826 · collaborator · 2025-12-22

RECRUITING

Digital Early Warning System for Acute Lung Injury in Liver SurgeryNCT07070362 · collaborator · 2024-11-01

RECRUITING

Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients With DiabetesNCT06331923 · collaborator · 2024-04-12

COMPLETED

TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)NCT04760431 · collaborator · 2021-10-01

UNKNOWN

SBRT With S1 Combined With Endostar in the Treatment of Lung CancerNCT04274270 · collaborator · 2020-04-01

UNKNOWN

The Treat-to-target Study of RA Based on Smart System of Disease Management(SSDM)NCT03715595 · collaborator · 2018-11-01

UNKNOWN

Sponsor roles

collaborator6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.